Pulmonx Corporation (LUNG) Earnings History
Net Loss8 years of earnings data (2018–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Pulmonx Corporation (LUNG) Earnings Overview
As of June 24, 2026, Pulmonx Corporation (LUNG) reported trailing twelve-month net income of -$53M, reflecting +7.6% year-over-year growth. The company earned $-1.27 per diluted share over the past four quarters, with a net profit margin of -59.7%.
Looking at the long-term picture, LUNG's historical earnings data spans multiple years. The company achieved its highest annual net income of -$18M in fiscal 2018.
Pulmonx Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including INSP ($131M net income, 15.9% margin), NVCR (-$173M net income, -20.8% margin), ATRC (-$5M net income, -2.1% margin), LUNG has room to improve margins relative to the peer group. Compare LUNG vs INSP →
LUNG Earnings vs Peers
Earnings metrics vs comparable public companies
LUNG Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$54M | +4.2% | -$54M | $-1.33 | -59.7% | -59.3% |
| 2024 | -$56M | +7.3% | -$58M | $-1.44 | -67.3% | -68.9% |
| 2023 | -$61M | -3.3% | -$62M | $-1.60 | -88.6% | -90.2% |
| 2022 | -$59M | -21.1% | -$59M | $-1.59 | -109.8% | -109.3% |
| 2021 | -$49M | -51.0% | -$47M | $-1.35 | -100.5% | -97.7% |
| 2020 | -$32M | -55.7% | -$32M | $-0.90 | -98.5% | -98.8% |
| 2019 | -$21M | -12.0% | -$18M | $-0.58 | -63.5% | -54.7% |
| 2018 | -$18M | - | -$15M | $-0.89 | -92.4% | -75.2% |
Download Data
Export LUNG earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
LUNG — Frequently Asked Questions
Quick answers to the most common questions about buying LUNG stock.
What is LUNG earnings per share (EPS)?
LUNG trailing twelve-month (TTM) diluted EPS is $-1.27, reflecting +7.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2018 to 2025 is available in the table on this page.
What is Pulmonx Corporation's net income?
Pulmonx Corporation (LUNG) trailing twelve-month net income is $-53M as of 2025. Earnings grew +7.6% year-over-year.
Is LUNG profitable?
LUNG is not currently profitable on a TTM basis, reporting a net loss of $-53M. Net margin is -59.7%. Investors should monitor for a return to profitability.
What is LUNG's earnings growth rate?
LUNG compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.
What are LUNG's profit margins?
Pulmonx Corporation net profit margin is -59.7%, operating margin is -59.3%, and gross margin is +74.2%. Below-average margins reflect competitive or cost pressures. Return on Equity is -77.2%.
Is LUNG growing earnings?
LUNG is growing earnings steadily. YoY EPS growth of +7.6% is consistent with the 5-year CAGR of N/A. TTM net income is $-53M.
What was LUNG's best earnings year?
Pulmonx Corporation's highest annual net income on record is $-18M, achieved in fiscal year 2018. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.
What were LUNG's earnings last quarter?
LUNG's most recent reported quarter was Q1 2026. Net income was $-14M with diluted EPS of $-0.33. For a full breakdown of all quarters, see the quarterly earnings table on this page.